Xcellerate® Recruitment Analysis & Forecasting, a built-for-purpose application, improves enrollment predictability and mitigates risk throughout a study to meet patient recruitment and delivery milestones.
Xcellerate Recruitment Analysis and Forecasting uses unique-to-the industry historical investigator data and artificial intelligence to forecast recruitment with detailed timelines before and during the enrollment period.
Our Analysis and Forecasting group applies our historic investigator recruitment performance data and experience of running Phase I dose escalation and expansion studies (cohort designs) in a study-tailored model to illustrate a possible outcome for patient recruitment. As the study progresses, cohorts are completed and data analysed, the models are adapted to reassess the delivery of recruitment and the planning of future studies.
Patient Recruitment is the biggest challenge in delivering clinical studies. Many studies are extremely volatile, and there are many ways to model a study. Xcellerate Recruitment Analysis and Forecasting can provide detailed and flexible projections to easily model any scenario. The application takes into account numerous factors to model the timelines for any given study to give a more realistic representation against expectations.
Some granular factors that our team can model against are site-specific data for start-up times, closure dates, recruitment rates, holiday periods and seasonality and study design strata and subgroups. Xcellerate Recruitment Analysis and Forecasting sets a minimum and/or maximum number of patients to be recruited within a country and/or regional level to measure the impact on enrollment. Continual assessment throughout the study allows for early identification of risks and development of mitigation plans.
网站性能指标提供insights into actual performance versus expectations and compare to prior months, highlighting sites where focus may be needed and estimating the likelihood of a site ever recruiting.
Our projections include AI projections of clinical endpoints (eg death, disease progression), providing a tighter control on when a study may end.
联系Us:
Schedule a Meeting/Demo
Contact Us
Covance by Labcorp is a leading global life sciences company, which provides contract research services to the drug, medical device and diagnostics, crop protection and chemical industries.
COVANCE is a registered trademark and the marketing name for Covance Inc. and its subsidiaries around the world.
.png){kind=icon}